EUVIMEDEUVIMED entdecken
KommentarOpen Access · CC BY-NC-ND 4.0

Serine supplementation: Is it a new option for the treatment of diabetic polyneuropathy?

Hiroki Mizukami iD

Journal of Diabetes Investigation · 2023

DOI: 10.1111/jdi.14047 ↗

Kurz gefasst

Kommentar in der Zeitschrift Journal of Diabetes Investigation, 2023. Verfasst von Hiroki Mizukami. Beteiligte Einrichtung: Department of Pathology and Molecular Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Diabetes Mellitus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesDiabetes MellitusHumansSerineDietary Supplements

Substanzen

Serine

Autor:innen und Institutionen

  • Department of Pathology and Molecular Medicine, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.

ORCID-Profile: Hiroki Mizukami

Zitieren

APA

Mizukami, H. (2023). Serine supplementation: Is it a new option for the treatment of diabetic polyneuropathy?. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.14047

Vancouver

Mizukami H. Serine supplementation: Is it a new option for the treatment of diabetic polyneuropathy?. Journal of Diabetes Investigation. 2023. doi:10.1111/jdi.14047

BibTeX
@article{Mizukami2023,
  author = {Mizukami, Hiroki},
  title = {Serine supplementation: Is it a new option for the treatment of diabetic polyneuropathy?},
  journal = {Journal of Diabetes Investigation},
  year = {2023},
  doi = {10.1111/jdi.14047}
}
Kostenlos starten →